GL1X · GenesisL1 explorer

MolNFT v1 · #141679 · protein

Crystal structure of beta-lactamase penp mutant-E166Y in complex with cephaloridine as "pre-deacylation" intermediate

5ZFT: “Crystal structure of beta-lactamase penp mutant-E166Y in complex with cephaloridine as "pre-deacylation"…”. X-ray diffraction, 1 ligand (CED), 4 pockets (best druggability 0.74). MolNFT v1 #141679 on GenesisL1: 3D structure, binding…

PDB
5ZFT
Type
protein
Length
515 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P00808
Ligands
CED
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein25843% helix, 18% strandP00808
BBeta-lactamase (EC 3.5.2.6)protein25743% helix, 18% strandP00808

Ligands and binding sites

  • CED · 5-methyl-2-[2-oxo-1-(2-thiophen-2-yl-acetylamino)-ethyl]-3,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111650.740.77102CED
2620.460.8416empty
3720.440.8117empty
4640.260.7317CED

Interfaces

1 interface between chains.

  • A–B · 631 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5ZFT · Crystal structure of beta-lactamase PenP mutant-E166Y in complex with cephaloridine as… · the same entry in another collection · chain B against B, TM-score 1.00
  • P00808 · AlphaFold monomer V2.0 prediction for beta-lactamase (P00808) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.